arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

MUSTANG BIO, INC.

MBIO
$0.58 0.00 (+0.68%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
43 Visible periods
21 Metrics
Peer-ranked Benchmarks
Price Chart
46
Health
Weak
Neutral
auto_awesome

Analytical Summary

MUSTANG BIO, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $3.9M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -9.7%
FCF / Share $-0.15
Trailing P/E
Price / Book 0.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

43-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-955.00K
↓ -524.2%
FCF / Share Free cash flow per share
$-0.15
↑ +69.1%

Health Breakdown

Returns
28
Cash Quality
91

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 43 quarters